Exact Mass: 419.9643836
Exact Mass Matches: 419.9643836
Found 47 metabolites which its exact mass value is equals to given mass value 419.9643836
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Inositol 1,3,4-trisphosphate
C6H15O15P3 (419.96238300000005)
Inositol 1,3,4-trisphosphate (CAS: 98102-63-7), also known as Ins(1,3,4)P3 or I3S, belongs to the class of organic compounds known as inositol phosphates. Inositol phosphates are compounds containing a phosphate group attached to an inositol (or cyclohexanehexol) moiety. Within humans, inositol 1,3,4-trisphosphate participates in several enzymatic reactions. In particular, inositol 1,3,4-trisphosphate can be converted into 1D-myo-inositol 1,3,4,6-tetrakisphosphate through the action of the enzyme inositol-tetrakisphosphate 1-kinase. In addition, inositol 1,3,4-trisphosphate can be converted into inositol 1,3,4,5-tetraphosphate through its interaction with the enzyme inositol-tetrakisphosphate 1-kinase. In humans, inositol 1,3,4-trisphosphate is involved in inositol metabolism. Inositol 1,3,4-trisphosphate is a specific regulator of cellular signalling. A specific regulator of cellular signaling [HMDB]
myo-Inositol 1,4,5-trisphosphate
C6H15O15P3 (419.96238300000005)
myo-Inositol 1,4,5-trisphosphate (CAS: 20298-95-7), also known as Ins(1,4,5)P3 or InsP3, is an intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane (PMID: 22453946). It is released into the cytoplasm where it releases calcium ions from internal stores within the cells endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin (PMID: 15189149). Its transient accumulation is due both to the enhanced metabolism via the Ca2+-calmodulin-sensitive Ins(1,4,5)P3 kinase, as well as a down-regulation of phosphatidylinositol 4,5-bisphosphate hydrolysis (PMID: 3041962). It is a major regulator of apoptotic signalling driving calcium (Ca2+) transients from the endoplasmic reticulum to mitochondria, thereby establishing a functional and physical link between these organelles. It also regulates autophagy through the interaction with Beclin 1 complex, and in particular, its inhibition/depletion strongly induces macroautophagy (PMID: 19325567). In addition, recent evidence suggests that the penetrating sperm delivers into mammalian eggs a novel isoform of phospholipase C (PLC), which promotes the formation of inositol 1,4,5-trisphosphate (PMID: 15362223). Intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane. Inositol 1,4,5-trisphosphate is released into the cytoplasm where it releases calcium ions from internal stores within the cells endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin. (PubChem)
Inositol 1,3,4-triphosphate
C6H15O15P3 (419.96238300000005)
Atrinositol
C6H15O15P3 (419.96238300000005)
[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl] phosphono hydrogen phosphate
C6H15O15P3 (419.96238300000005)
(1R-cis)-4-Bromo-2-(1,2-dimethyl-3-methylenecyclopentyl)-3-iodo-5-methylphenol
C15H18BrIO (419.95857079999996)
Iodoether A
C15H18BrIO (419.95857079999996)
5-(3,5-Dibromo-4-(3-dimethylaminopropoxy)phenyl)-4,5-dihydrooxazole-2(3H)-one
4-Bromo-9-(iodomethyl)-1,5,12-trimethyl-8-oxatricyclo dodeca-2,4,6-triene
C15H18BrIO (419.95857079999996)
alpha-Trinositol
C6H15O15P3 (419.96238300000005)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
D-myo-Inositol-2,4,5-triphosphate
C6H15O15P3 (419.96238300000005)
D-myo-Inositol-1,2,6-triphosphate
C6H15O15P3 (419.96238300000005)
D-myo-Inositol-1,3,5-triphosphate
C6H15O15P3 (419.96238300000005)
D-myo-Inositol-1,5,6-triphosphate
C6H15O15P3 (419.96238300000005)
D-myo-Inositol-2,3,5-triphosphate
C6H15O15P3 (419.96238300000005)
D-myo-inositol-2,5,6-triphosphate
C6H15O15P3 (419.96238300000005)
D-myo-Inositol-3,4,5-triphosphate
C6H15O15P3 (419.96238300000005)
L-myo-Inositol-1,4,5-triphosphate
C6H15O15P3 (419.96238300000005)
D-myo-Inositol-1,4,6-triphosphate
C6H15O15P3 (419.96238300000005)
D-myo-Inositol-1,3,4-triphosphate (sodium salt)
C6H15O15P3 (419.96238300000005)
myo-Inositol, 1,3,5-tris(dihydrogen phosphate)
C6H15O15P3 (419.96238300000005)
Pentamethylcyclopentadienylhafnium trichloride
C10H15Cl3Hf (419.97048900000004)
Atrinositol
C6H15O15P3 (419.96238300000005)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
1D-myo-inositol 3,4,6-trisphosphate
C6H15O15P3 (419.96238300000005)
[(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate
C6H15O15P3 (419.96238300000005)
[(1S,2R,4S,5S)-2,3,4-Trihydroxy-5,6-diphosphonooxycyclohexyl] dihydrogen phosphate
C6H15O15P3 (419.96238300000005)
1D-Myo-inositol 1,4,5-trisphosphate
C6H15O15P3 (419.96238300000005)
1D-myo-Inositol 1,2,6-trisphosphate
C6H15O15P3 (419.96238300000005)
[(1r,2r,3s,4s,5r,6r)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxyphosphonic acid
C6H15O15P3 (419.96238300000005)
4-bromo-9-(iodomethyl)-1,5,12-trimethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-triene
C15H18BrIO (419.95857079999996)
4-bromo-6-[(1s,2r,5r)-1,2-dimethylbicyclo[3.1.0]hexan-2-yl]-2-iodo-3-methylphenol
C15H18BrIO (419.95857079999996)
4-bromo-6-{1,2-dimethylbicyclo[3.1.0]hexan-2-yl}-2-iodo-3-methylphenol
C15H18BrIO (419.95857079999996)
(1s,9r,12s)-4-bromo-9-(iodomethyl)-1,5,12-trimethyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2(7),3,5-triene
C15H18BrIO (419.95857079999996)
4-bromo-2-(1,2-dimethyl-3-methylidenecyclopentyl)-3-iodo-5-methylphenol
C15H18BrIO (419.95857079999996)
4-bromo-2-[(1r,2s)-1,2-dimethyl-3-methylidenecyclopentyl]-3-iodo-5-methylphenol
C15H18BrIO (419.95857079999996)
[(1s,2r,3r,4s,5s,6s)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxyphosphonic acid
C6H15O15P3 (419.96238300000005)
(3z,6s)-3-(3,3-dichloro-2-methylprop-2-en-1-ylidene)-1,4-dimethyl-6-[(2s)-3,3,3-trichloro-2-methylpropyl]piperazine-2,5-dione
C14H17Cl5N2O2 (419.97326119999997)
[(1r,2s,3r,4r,5s,6r)-2,4,5-trihydroxy-3,6-bis(phosphonooxy)cyclohexyl]oxyphosphonic acid
C6H15O15P3 (419.96238300000005)